Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implications.
Patients with diabetes mellitus, chronic renal disease, or advanced age who are undergoing percutaneous coronary intervention are at an increased risk of bleeding and thrombosis. This article reviews the clinical implications of these conditions and discusses the therapeutic options currently available for these patient groups.
Schneider
David J
DJ
Cardiology Division, Department of Medicine, University of Vermont, Burlington, Vermont, USA.
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D048909:Diabetes Complications / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006470:Hemorrhage / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000150:complications*; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors